Antisocial Personality Disorder's Very Limited Pharmacologic Role
Court-mandated after an assault conviction, a man with antisocial personality disorder and heavy alcohol use is referred for 'anger treatment.' The disagreement is whether to medicate the aggression directly or redirect to the one diagnosis in the room that actually has evidence behind it.
T.B., a 34-year-old man, was placed on probation six weeks ago after pleading guilty to assault following a bar fight he says started because “the guy wouldn't stop looking at me the wrong way” — his third alcohol-related legal incident in five years, following a DUI at twenty-nine and a disorderly conduct charge at thirty-one. Psychiatric evaluation is a condition of his probation, not something he requested, and he says so directly and without apparent embarrassment in the first minute of the visit.
His history, corroborated by his probation file and by his own account, shows a pattern extending back to adolescence: expulsion from high school at sixteen for a physical altercation with a teacher, a juvenile record he describes with something closer to pride than regret, a string of jobs ended by conflicts with supervisors, and two prior romantic relationships that ended, by his description, after “she got dramatic about stuff that wasn't a big deal.” He meets criteria for antisocial personality disorder, formally documented by conduct problems before age fifteen. He also drinks heavily — most days, often to intoxication, a pattern he does not describe as a problem so much as “how I unwind,” despite it being present in some form at every one of his three legal incidents.
The referral question, as his probation officer framed it, is whether medication can help with “the anger.” But the actual clinical picture in front of the team has two components that respond very differently to pharmacology: a personality-level pattern of aggression and rule-violation with essentially no dedicated drug evidence behind it, and a separate, well-characterized alcohol use disorder that does. Separating the two on paper is easy. Separating them in a man who has never experienced one without the other — while a probation officer waits for an answer — is the harder, real task in front of the team today.
Court-mandated psychiatric evaluation
The referral question is specifically about his aggression, and I don't think it's fair to say there's nothing in the literature at all. Older studies on impulsive aggression — Sheard's lithium trials from the 1970s, for instance — found real reductions in aggressive incidents with mood-stabilizing agents in populations with a similar behavioral profile. Given the actual referral reason is a violent incident and public-safety stakes are real here, I think there's at least an argument for trying something aimed at the aggression directly, rather than declining to address the one thing everyone actually asked about.
I understand why the referral question pulls in that direction — the probation office wants to know the aggression is being addressed, and “we're not treating that” sounds like a non-answer to them.
But the lithium-and-aggression literature you're citing wasn't conducted in antisocial personality disorder specifically, and NICE's 2009 guideline on ASPD, after reviewing the actual trial evidence for this diagnosis, is direct about it: pharmacological interventions should not be routinely used for antisocial personality disorder or for associated behaviors of aggression, anger, and impulsivity. That's not caution for its own sake — it reflects that trait-level, characterological aggression like his doesn't respond to medication the way aggression secondary to a mood or psychotic disorder does, and he has no mood or psychotic disorder here. Medicating a personality trait because it produced a visible, prosecutable incident risks treating this as chemical behavior control in a context where he has no real ability to decline — that's a real ethical problem, not just an evidence one.
I'd redirect the whole question. He has alcohol use disorder, present at every one of his three legal incidents, and that diagnosis has real pharmacotherapy with genuine trial support — naltrexone specifically, which reduces heavy drinking days regardless of what personality sits alongside it. We're not medicating his personality, and we're not pretending to. We're treating a real, separate, comorbid diagnosis that happens to be the thing most consistently present when things go wrong for him. If it also reduces the frequency of incidents like the one that put him on probation, that's a genuine clinical benefit, not a workaround — but it's honest about what the drug is actually treating.
Agreed: naltrexone started for the diagnosed alcohol use disorder, explained to T.B. directly and honestly as treatment for his drinking, not his personality and not a probation-compliance tool. The team documented the same distinction in the report sent to his probation officer — alcohol use disorder is being treated pharmacologically; antisocial personality disorder itself is not, because the evidence does not support doing so.
The team notes any accompanying reduction in conflict or legal incidents as a plausible downstream benefit, without claiming naltrexone treated his personality disorder.
Naltrexone is reassessed as AUD pharmacotherapy on its own terms; no personality- targeted medication is added in its place.
Not agreed: the Attending Psychiatrist remained concerned that an honest report stating plainly that “the anger” itself is not being pharmacologically treated could read to probation staff as non-compliance with the spirit of the referral; the Psychiatric Pharmacist and Addiction Medicine Specialist held that documenting the actual evidence honestly was the correct choice regardless of how it is read.